GAS5 and chronic obstructive pulmonary disease: GAS5 modulates the activity of key signaling pathways involved in COPD pathogenesis, including NF-κB and JAK-STAT signaling, by binding to the glucocorticoid receptor and sequestering miRNAs such as miR-21, which in turn modulates the expression of target genes [163].